Infections in Pediatric Patients With Hematologic Malignancies

Seminars in Hematology

Volumn 46, Issue 3, 2009, Pages 313-324

  Bailey, L Charles ^a   Reilly, Anne F ^a   Rheingold, Susan R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CILASTATIN PLUS IMIPENEM; CYTARABINE; GENTAMICIN; HEPATITIS B VACCINE; IMMUNOGLOBULIN G; INFLUENZA VACCINE; INTERFERON; MEROPENEM; METICILLIN; METRONIDAZOLE; NAFCILLIN; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TICARCILLIN; TOBRAMYCIN; UNINDEXED DRUG; VANCOMYCIN; VARICELLA ZOSTER VACCINE;

ADENOVIRUS; ADENOVIRUS INFECTION; ANTIBIOTIC SENSITIVITY; ARTICLE; ASPERGILLOSIS; BACTERIAL INFECTION; BACTERIAL STRAIN; CANDIDA; CANDIDIASIS; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; DRUG EFFECT; DRUG EFFICACY; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; GRAM POSITIVE BACTERIUM; GRAM POSITIVE INFECTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS B; HEPATITIS C; HERPES VIRUS; HERPES ZOSTER; HIGH RISK PATIENT; HUMAN; INFECTION RISK; INFLUENZA; MONOTHERAPY; MORBIDITY; MUCOSA INFLAMMATION; MYCOSIS; NONHUMAN; PARVOVIRUS; PARVOVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY VIRUS; STAPHYLOCOCCAL BACTEREMIA; VIRUS INFECTION;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ANTIVIRAL AGENTS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; HEMATOLOGIC NEOPLASMS; HUMANS; MYCOSES; VIRUS DISEASES;

EID: 67249083364     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2009.03.010     Document Type: Article

References (103)

1. Christensen M.S., Heyman M., Mottonen M., Zeller B., Jonmundsson G., and Hasle H. Treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992-2001. Br J Haematol. 131 (2005) 50-58
2. Seibel N.L., Steinherz P.G., Sather H.N., Nachman J.B., Delaat C., Ettinger L.J., et al. Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 111 (2008) 2548-2555
3. Moricke A., Reiter A., Zimmermann M., Gadner H., Stanulla M., Dordelmann M., et al. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood 111 (2008) 4477-4489
4. Creutzig U., Zimmermann M., Reinhardt D., Dworzak M., Stary J., and Lehrnbecher T. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol. 22 (2004) 4384-4393
5. Sung L., Lange B.J., Gerbing R.B., Alonzo T.A., and Feusner J. Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia. Blood 110 (2007) 3532-3539
6. Raetz E.A., Borowitz M.J., Devidas M., Linda S.B., Hunger S.P., Winick N.J., et al. Reinduction platform for children with first marrow relapse of acute lymphoblastic leukemia: a Children's Oncology Group study. J Clin Oncol. 26 (2008) 3971-3978
7. Hilden J.M., Dinndorf P.A., Meerbaum S.O., Sather H., Villaluna D., Heerema N.A., et al. Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group. Blood 108 (2006) 441-451
8. Lausen B., Schmiegelow K., Andreassen B., Madsen H.O., and Garred P. Infections during induction therapy of childhood acute lymphoblastic leukemia-no association to mannose-binding lectin deficiency. Eur J Haematol. 76 (2006) 481-487
9. Auletta J.J., O'Riordan M.A., and Nieder M.L. Infections in children with cancer: a continued need for the comprehensive physical examination. J Pediatr Hematol Oncol. 21 (1999) 501-508
10. Viscoli C., Castagnola E., Giacchino M., Cesaro S., Properzi E., Tucci F., et al. Bloodstream infections in children with cancer: a multicentre surveillance study of the Italian Association of Paediatric Haematology and Oncology. Supportive Therapy Group-Infectious Diseases Section. Eur J Cancer 35 (1999) 770-774
11. Castagnola E., Fontana V., Caviglia I., Caruso S., Faraci M., Fioredda F., et al. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clin Infect Dis. 45 (2007) 1296-1304
12. Thomson B., Park J.R., Felgenhauer J., Meshinchi S., Holcenberg J., Geyer J.R., et al. Toxicity and efficacy of intensive chemotherapy for children with acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse. Pediatr Blood Cancer 43 (2004) 571-579
13. Erdur B., Yilmaz S., Oren H., Demircioglu F., Cakmakc H., and Irken G. Evaluating pulmonary complications in childhood acute leukemias. J Pediatr Hematol Oncol. 30 (2008) 522-526
14. Harris M.B., Shuster J.J., Pullen J., Borowitz M.J., Carroll A.J., Behm F.G., et al. Treatment of children with early pre-B and pre-B acute lymphocytic leukemia with antimetabolite-based intensification regimens: a Pediatric Oncology Group study. Leukemia 14 (2000) 1570-1576
15. Castagnola E., Caviglia I., Pistorio A., Fioredda F., Micalizzi C., Viscoli C., et al. Bloodstream infections and invasive mycoses in children undergoing acute leukaemia treatment: a 13-year experience at a single Italian institution. Eur J Cancer 41 (2005) 1439-1445
16. Gamis A.S., Howells W.B., DeSwarte-Wallace J., Feusner J.H., Buckley J.D., and Woods W.G. Alpha hemolytic streptococcal infection during intensive treatment for acute myeloid leukemia: a report from the Children's Cancer Group study CCG-2891. J Clin Oncol. 18 (2000) 1845-1855
17. Sung L., Gamis A., Alonzo T.A., Buxton A., Britton K., Deswarte-Wallace J., et al. Infections and association with different intensity of chemotherapy in children with acute myeloid leukemia. Cancer 115 (2009) 1100-1108
18. Hurwitz C.A., Silverman L.B., Schorin M.A., Clavell L.A., Dalton V.K., Glick K.M., et al. Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia. Cancer 88 (2000) 1964-1969
19. Cesaro S., Chinello P., De Silvestro G., Marson P., Picco G., Varotto S., et al. Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases. Support Care Cancer 11 (2003) 101-106
20. Santolaya M.E., Alvarez A.M., Becker A., Cofre J., Enriquez N., O'Ryan M., et al. Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. J Clin Oncol. 19 (2001) 3415-3421
21. Bakhshi S., Padmanjali K.S., and Arya L.S. Infections in childhood acute lymphoblastic leukemia: an analysis of 222 febrile neutropenic episodes. Pediatr Hematol Oncol. 25 (2008) 385-392
22. Jagarlamudi R., Kumar L., Kochupillai V., Kapil A., Banerjee U., and Thulkar S. Infections in acute leukemia: an analysis of 240 febrile episodes. Med Oncol (Northwood, London, England) 17 (2000) 111-116
23. Hengartner H., Berger C., Nadal D., Niggli F.K., and Grotzer M.A. Port-A-Cath infections in children with cancer. Eur J Cancer 40 (2004) 2452-2458
24. Adler A., Yaniv I., Solter E., Freud E., Samra Z., Stein J., et al. Catheter-associated bloodstream infections in pediatric hematology-oncology patients: factors associated with catheter removal and recurrence. J Pediatr Hematol Oncol. 28 (2006) 23-28
25. Rubin L.G., Shih S., Shende A., Karayalcin G., and Lanzkowsky P. Cure of implantable venous port-associated bloodstream infections in pediatric hematology-oncology patients without catheter removal. Clin Infect Dis. 29 (1999) 102-105
26. Vuong C., and Otto M. Staphylococcus epidermidis infections. Microbes Infect Inst Pasteur. 4 (2002) 481-489
27. Bochud P.Y., Eggiman P., Calandra T., Van Melle G., Saghafi L., and Francioli P. Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors. Clin Infect Dis. 18 (1994) 25-31
28. Feusner J., Alonzo T., Dinndorf P., et al. Infectious complications of intensive chemotherapy on Childrens' Cancer Group protocol CCG-2961 for pediatric acute myeloid leukemia. [abstract 1287]. Blood 100 (2002) 332a
29. Ruescher T.J., Sodeifi A., Scrivani S.J., Kaban L.B., and Sonis S.T. The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies. Cancer 82 (1998) 2275-2281
30. Rossetti F., Cesaro S., Putti M.C., and Zanesco L. High-dose cytosine arabinoside and viridans streptococcus sepsis in children with leukemia. Pediatr Hematol Oncol. 12 (1995) 387-392
31. Sotiropoulos S.V., Jackson M.A., Woods G.M., Hicks R.A., Cullen J., and Freeman A.I. Alpha-streptococcal septicemia in leukemic children treated with continuous or large dosage intermittent cytosine arabinoside. Pediatr Infect Dis J. 8 (1989) 755-758
32. Reilly A.F., and Lange B.J. Infections with viridans group streptococci in children with cancer. Pediatr Blood Cancer 49 (2007) 774-780
33. Graber C.J., de Almeida K.N., Atkinson J.C., Javaheri D., Fukuda C.D., Gill V.J., et al. Dental health and viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 27 (2001) 537-542
34. Tunkel A.R., and Sepkowitz K.A. Infections caused by viridans streptococci in patients with neutropenia. Clin Infect Dis. 34 (2002) 1524-1529
35. Elting L.S., Bodey G.P., and Keefe B.H. Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infect Dis. 14 (1992) 1201-1207
36. Shenep J.L. Viridans-group streptococcal infections in immunocompromised hosts. Int J Antimicrob Agents 14 (2000) 129-135
37. Marron A., Carratala J., Gonzalez-Barca E., Fernandez-Sevilla A., Alcaide F., and Gudiol F. Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer. Clin Infect Dis. 31 (2000) 1126-1130
38. Richard P., Amador Del Valle G., Moreau P., Milpied N., Felice M.P., Daeschler T., et al. Viridans streptococcal bacteraemia in patients with neutropenia. Lancet 345 (1995) 1607-1609
39. Martino R., Manteiga R., Sanchez I., Brunet S., Sureda A., Badell I., et al. Viridans streptococcal shock syndrome during bone marrow transplantation. Acta Haematol. 94 (1995) 69-73
40. Sandlund J.T., Howard S.C., Hijiya N., Pui C.H., Shenep J.L., and Adderson E.E. Myositis complicating viridans streptococcal sepsis in childhood leukemia. Pediatr Blood Cancer 44 (2005) 277-279
41. Leblanc T., Leverger G., Arlet G., Siguret V., and Schaison G. [Frequency and severity of systemic infections caused by Streptococcus mitis and sanguis II in neutropenic children]. Pathol Biol. 37 (1989) 459-464
42. Villablanca J.G., Steiner M., Kersey J., Ramsay N.K., Ferrieri P., Haake R., et al. The clinical spectrum of infections with viridans streptococci in bone marrow transplant patients. Bone Marrow Transplant 5 (1990) 387-393
43. Elting L.S., Rubenstein E.B., Rolston K.V., and Bodey G.P. Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clin Infect Dis. 25 (1997) 247-259
44. Gassas A., Grant R., Richardson S., Dupuis L.L., Doyle J., Allen U., et al. Predictors of viridans streptococcal shock syndrome in bacteremic children with cancer and stem-cell transplant recipients. J Clin Oncol. 22 (2004) 1222-1227
45. Singh T.N., Devi K.M., and Devi K.S. Ecthyma gangrenosum: a rare cutaneous manifestation caused by pseudomonas aeruginosa without bacteraemia in a leukaemic patient-a case report. Ind J Med Microbiol. 23 (2005) 262-263
46. Kapil A., Gulati S., Goel V., Kumar L., Krishnan R., and Kochupillai V. Outbreak of nosocomial Acinetobacter baumannii bacteremia in a high risk ward. Med Oncol (Northwood, London, England) 15 (1998) 270-274
47. Adler A., Yaniv I., Steinberg R., Solter E., Samra Z., Stein J., et al. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients. J Hosp Infect. 62 (2006) 358-365
48. Rolston K.V. The Infectious Diseases Society of America 2002 guidelines for the use of antimicrobial agents in patients with cancer and neutropenia: salient features and comments. Clin Infect Dis. 39 Suppl 1 (2004) S44-S48
49. Yildirim I., Aytac S., Ceyhan M., Cetin M., Tuncer M., Cengiz A.B., et al. Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies. Pediatr Hematol Oncol. 25 (2008) 291-299
50. Paul M., Yahav D., Fraser A., and Leibovici L. Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials. J Antimicrobial Chemother. 57 (2006) 176-189
51. Rolston K.V., and Bodey G.P. Comment on: empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials. J Antimicrobial Chemother. 58 (2006) 478
52. Corapcioglu F., Sarper N., and Zengin E. Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison. Pediatr Hematol Oncol. 23 (2006) 177-186
53. Ariffin H., Ai C.L., Lee C.L., and Abdullah W.A. Cefepime monotherapy for treatment of febrile neutropenia in children. J Paediatr Child Health 42 (2006) 781-784
54. Mustafa M.M., Carlson L., Tkaczewski I., McCracken Jr. G.H., and Buchanan G.R. Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia. Pediatr Infect Dis J 20 (2001) 362-369
55. Castagnola E., Haupt R., Micozzi A., Caviglia I., Testi A.M., Giona F., et al. Differences in the proportions of fluoroquinolone-resistant gram-negative bacteria isolated from bacteraemic children with cancer in two Italian centres. Clin Microbiol Infect. 11 (2005) 505-507
56. Kurt B., Flynn P., Shenep J.L., Pounds S., Lensing S., Ribeiro R.C., et al. Prophylactic antibiotics reduce morbidity due to septicemia during intensive treatment for pediatric acute myeloid leukemia. Cancer 113 (2008) 376-382
57. Paul M., Gafter-Gvili A., Leibovici L., Bishara J., Levy I., Yaniv I., et al. The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988-2004. Isr Med Assoc J 9 (2007) 424-429
58. Leibovici L., Paul M., Poznanski O., Drucker M., Samra Z., Konigsberger H., et al. Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study. Antimicrobial Agents Chemother. 41 (1997) 1127-1133
59. Pizzo P.A., Robichaud K.J., Gill F.A., Witebsky F.G., Levine A.S., Deisseroth A.B., et al. Duration of empiric antibiotic therapy in granulocytopenic patients with cancer. Am J Med. 67 (1979) 194-200
60. Mullen C.A. Ciprofloxacin in treatment of fever and neutropenia in pediatric cancer patients. Pediatr Infect Dis J 22 (2003) 1138-1142
61. Link H., Bohme A., Cornely O.A., Hoffken K., Kellner O., Kern W.V., et al. Antimicrobial therapy of unexplained fever in neutropenic patients-guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society). Ann Hematol. 82 Suppl 2 (2003) S105-S117
62. Simon A., Bode U., and Beutel K. Diagnosis and treatment of catheter-related infections in paediatric oncology: an update. Clin Microbiol Infect. 12 (2006) 606-620
63. Safdar A., and Rolston K.V. Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin Infect Dis. 45 (2007) 1602-1609
64. Paulino A.F., Kenney R., Forman E.N., and Medeiros L.J. Typhlitis in a patient with acute lymphoblastic leukemia prior to the administration of chemotherapy. Am J Pediatr Hematol Oncol. 16 (1994) 348-351
65. Otaibi A.A., Barker C., Anderson R., and Sigalet D.L. Neutropenic enterocolitis (typhlitis) after pediatric bone marrow transplant. J Pediatr Surg. 37 (2002) 770-772
66. Kelly K.M., Hutchinson R.J., Sposto R., Weiner M.A., Lones M.A., Perkins S.L., et al. Feasibility of upfront dose-intensive chemotherapy in children with advanced-stage Hodgkin's lymphoma: preliminary results from the Children's Cancer Group study CCG-59704. Ann Oncol. 13 Suppl 1 (2002) 107-111
67. McCarville M.B., Adelman C.S., Li C., Xiong X., Furman W.L., Razzouk B.I., et al. Typhlitis in childhood cancer. Cancer 104 (2005) 380-387
68. Sloas M.M., Flynn P.M., Kaste S.C., and Patrick C.C. Typhlitis in children with cancer: a 30-year experience. Clin Infect Dis. 17 (1993) 484-490
69. Wade J.C. Viral infections in patients with hematological malignancies. Hematol Am Soc Hematol Educ Program (2006) 368-374
70. Christensen M.S., Nielsen L.P., and Hasle H. Few but severe viral infections in children with cancer: a prospective RT-PCR and PCR-based 12-month study. Pediatr Blood Cancer 45 (2005) 945-951
71. Koskenvuo M., Mottonen M., Rahiala J., Saarinen-Pihkala U.M., Riikonen P., Waris M., et al. Respiratory viral infections in children with leukemia. Pediatr Infect Dis J 27 (2008) 974-980
72. Mendoza Sanchez M.C., Ruiz-Contreras J., Vivanco J.L., Fernandez-Carrion F., Baro Fernandez M., Ramos J.T., et al. Respiratory virus infections in children with cancer or HIV infection. J Pediatr Hematol Oncol. 28 (2006) 154-159
73. Sung L., Alonzo T.A., Gerbing R.B., Aplenc R., Lange B.J., Woods W.G., et al. Respiratory syncytial virus infections in children with acute myeloid leukemia: a report from the Children's Oncology Group. Pediatr Blood Cancer 51 (2008) 784-786
74. El Saleeby C.M., Somes G.W., DeVincenzo J.P., and Gaur A.H. Risk factors for severe respiratory syncytial virus disease in children with cancer: the importance of lymphopenia and young age. Pediatrics 121 (2008) 235-243
75. Porter C.C., Edwards K.M., Zhu Y., and Frangoul H. Immune responses to influenza immunization in children receiving maintenance chemotherapy for acute lymphoblastic leukemia. Pediatr Blood Cancer 42 (2004) 36-40
76. Porter C.C., Poehling K.A., Hamilton R., Frangoul H., and Cooper W.O. Influenza immunization practices among pediatric oncologists. J Pediatr Hematol Oncol. 25 (2003) 134-138
77. Report of the Committee on Influenza. In: Pickering L., Baker C., Overturf G., and Prober C. (Eds). AAP Red Book (2006), American Academy of Pediatrics, Elk Grove Village, IL 401-411
78. Hough R., Chetwood A., Sinfield R., Welch J., and Vora A. Fatal adenovirus hepatitis during standard chemotherapy for childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 27 (2005) 67-72
79. Hill G., Chauvenet A.R., Lovato J., and McLean T.W. Recent steroid therapy increases severity of varicella infections in children with acute lymphoblastic leukemia. Pediatrics 116 (2005) e525-e529
80. Report of the Committee on Varicella. In: Pickering L., Baker C., Overturf G., and Prober C. (Eds). AAP Red Book (2006), American Academy of Pediatrics, Elk Grove Village, IL 711-725
81. Sartori A.M. A review of the varicella vaccine in immunocompromised individuals. Int J Infect Dis. 8 (2004) 259-270
82. Report of the Committee on Cytomegalovirus. In: Pickering L., Baker C., Overturf G., and Prober C. (Eds). AAP Red Book (2006), American Academy of Pediatrics, Elk Grove Village, IL 273-277
83. Firpi R.J., and Nelson D.R. Viral hepatitis: manifestations and management strategy. Hematol Am Soc Hematol Educ Program (2006) 375-380
84. Tibes R., Keating M.J., Ferrajoli A., Wierda W., Ravandi F., Garcia-Manero G., et al. Activity of alemtuzumab in patients with CD52-positive acute leukemia. Cancer 106 (2006) 2645-2651
85. Lindblom A., Heyman M., Gustafsson I., Norbeck O., Kaldensjo T., Vernby A., et al. Parvovirus B19 infection in children with acute lymphoblastic leukemia is associated with cytopenia resulting in prolonged interruptions of chemotherapy. Clin Infect Dis. 46 (2008) 528-536
86. Rosen G.P., Nielsen K., Glenn S., Abelson J., Deville J., and Moore T.B. Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution. J Pediatr Hematol Oncol. 27 (2005) 135-140
87. Martin G.S., Mannino D.M., Eaton S., and Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 348 (2003) 1546-1554
88. Grigull L., Beier R., Schrauder A., Kirschner P., Loening L., Jack T., et al. Invasive fungal infections are responsible for one-fifth of the infectious deaths in children with ALL. Mycoses 46 (2003) 441-446
89. Lehrnbecher T., Kaiser J., Varwig D., Ritter J., Groll A.H., Creutzig U., et al. Antifungal usage in children undergoing intensive treatment for acute myeloid leukemia: analysis of the multicenter clinical trial AML-BFM 93. Eur J Clin Microbiol Infect Dis. 26 (2007) 735-738
90. Bow E.J. Of yeasts and hyphae: a hematologist's approach to antifungal therapy. Hematol Am Soc Hematol Educ Program (2006) 361-367
91. Zaoutis T.E., Foraker E., McGowan K.L., Mortensen J., Campos J., Walsh T.J., et al. Antifungal susceptibility of Candida spp. isolated from pediatric patients: a survey of 4 children's hospitals. Diagn Microbiol Infect Dis. 52 (2005) 295-298
92. Steinbach W.J., and Walsh T.J. Mycoses in pediatric patients. Infect Dis Clin North Am. 20 (2006) 663-678
93. Gozdasoglu S., Ertem M., Buyukkececi Z., Yavuzdemir S., Bengisun S., Ozenci H., et al. Fungal colonization and infection in children with acute leukemia and lymphoma during induction therapy. Med Pediatr Oncol. 32 (1999) 344-348
94. Alberth M., Majoros L., Kovalecz G., Borbas E., Szegedi I., Marton I.J., et al. Significance of oral Candida infections in children with cancer. Pathol Oncol Res. 12 (2006) 237-241
95. Sallah S., Wan J.Y., Nguyen N.P., Vos P., and Sigounas G. Analysis of factors related to the occurrence of chronic disseminated candidiasis in patients with acute leukemia in a non-bone marrow transplant setting: a follow-up study. Cancer 92 (2001) 1349-1353
96. Zaoutis T.E., Greves H.M., Lautenbach E., Bilker W.B., and Coffin S.E. Risk factors for disseminated candidiasis in children with candidemia. Pediatr Infect Dis J. 23 (2004) 635-641
97. Gorschluter M., Mey U., Strehl J., Schmitz V., Rabe C., Pauls K., et al. Invasive fungal infections in neutropenic enterocolitis: a systematic analysis of pathogens, incidence, treatment and mortality in adult patients. BMC Infect Dis. 6 (2006) 35
98. Muller F.M., Trusen A., and Weig M. Clinical manifestations and diagnosis of invasive aspergillosis in immunocompromised children. Eur J Pediatr. 161 (2002) 563-574
99. Zaoutis T.E., Heydon K., Chu J.H., Walsh T.J., and Steinbach W.J. Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000. Pediatrics 117 (2006) e711-e716
100. Hayden R., Pounds S., Knapp K., Petraitiene R., Schaufele R.L., Sein T., et al. Galactomannan antigenemia in pediatric oncology patients with invasive aspergillosis. Pediatr Infect Dis J. 27 (2008) 815-819
101. Hovi L., Saxen H., Saarinen-Pihkala U.M., Vettenranta K., Meri T., and Richardson M. Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders. Pediatr Blood Cancer 48 (2007) 28-34
102. Wirth F., Perry R., Eskenazi A., Schwalbe R., and Kao G. Cutaneous mucormycosis with subsequent visceral dissemination in a child with neutropenia: a case report and review of the pediatric literature. J Am Acad Dermatol. 36 (1997) 336-341
103. Zaoutis T.E., Roilides E., Chiou C.C., Buchanan W.L., Knudsen T.A., Sarkisova T.A., et al. Zygomycosis in children: a systematic review and analysis of reported cases. Pediatr Infect Dis J. 26 (2007) 723-727